Eliquis linked with lower risk for post-polypectomy bleeding

178797

February 23, 2021

1 min read

Source/Disclosures

Published by:

Disclosures: The authors report no relevant financial disclosures.

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

ADDED TO EMAIL ALERTS

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Patients who received Eliquis were at lower risk for post-polypectomy bleeding and thromboembolism than those who received warfarin and other direct oral anticoagulants, according to study results.

Francis KL Chan, from the department of medicine and therapeutics at The Chinese University of Hong Kong, and colleagues wrote that the difference among competing anticoagulants in terms of post-polypectomy bleeding risk has not been fully explored.

“In this territory-wide population-based study, we aimed to evaluate the bleeding and thromboembolic risks after colonoscopic polypectomy among warfarin and [direct oral anticoagulants (DOAC)] users to address the current knowledge gap and unmet clinical need,” they wrote…

Want to know more click here go to source.

From -
Close
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close